Testimonials with Schär Engineering AG/Ltd. have been written before the change of the company name to SCHAER PROTON AG.

CNAO (Centro Nazionale di Adroterapia Oncologica)

“CNAO – National Center for oncological hadrontherapy (www.cnao.it) has referred and continually does to Schär Engineering Ltd. for the patient positioning system of the treatment rooms of our center.
We are pleased with the high technical performance and the interfacing skills demonstrated by Schär Engineering Ltd. for the development of our project.”

Mr. Yves Jongen

– Chief Research Officer of IBA (Ion Beam Applications) –

“For many years, Schaer Engineering has been one of the most reliable partners from IBA for IBA Proton Therapy Systems. The Patient Positioner Devices built by Schaer Engineering are extremely accurate and are a good illustration of Swiss engineering at its best. They conform carefully to the applicable standards and norms in this demanding field, and the after sales service has been very good too.”

Dr. Andrzej Kacperek

– Head of Ocular Proton Service of the National Eye Proton Therapy Centre (The Clatterbridge Cancer Centre NHS Foundation Trust) –

“We are very pleased with the Eye Treatment Chair that Schär Engineering Ltd. has produced for us. As we are a busy, specialist clinical service, we appreciated the excellent coordination, with minimal disruption to treatments, which was a vital aspect of this purchase. The Eye Treatment Chair has fulfilled our expectations, and we can say categorically, that this device has considerably improved the efficiency of the clinical service, as well as the experience undergone by the patients.”

Dr. Detlef Krischel

– Former ACCEL Instruments Division Head for PT Systems, Circular Accelerators and Magnets –

“Schär Engineering (in short: Schär) had been selected in 2002 by former ACCEL Instruments GmbH, Germany, to supply Gantries and Patient Positioners for its Proton Therapy System for the Rinecker PT Center in Munich. The awarding criteria were a reasonable pricing and Schär`s earlier supplies to the PSI providing an excellent reference. The scope of services of Schär included the assembly, installation, and commissioning on site. It was a very fruitful collaboration due to the fact that also Schär was ready to contribute their full scope of engineering competences to find viable and cost effective solutions in this first of a kind project for ACCEL An open reporting of their progress of work, excellent hardware quality fulfilling or exceeding specifications, and deliveries on time made this a very successful project.”

Dr. Eros Pedroni

– Former technological Project Manager of the Proton Therapy at the Paul Scherrer Institutes (PSI) –

“Schär Engineering (SEAG) has been since 1990 the main provider of the mechanical components of the proton therapy facility of PSI. The two gantry prototypes of PSI, Gantry 1 and Gantry 2, are well known in the field for having pioneered the development of pencil beam scanning. The skills, flexibility and cooperative spirit of the company were best proven by the achieved precision, functionality and high quality of the end products. The open attitude towards innovative technological solutions and the efficient handling of the commercial aspects of a rapidly evolving project were of decisive importance for the realization of the most modern systems of their time.”

PD Dr. med. Dr. med. habil. Hans Rinecker

– Chairman of the supervisory board of PROHEALTH AG –

“Schär Engineering is and has been a highly reliable partner for the RPTC over the past years. The gantries at RPTC offer the highest level of flexibility with respect to the beam direction, requiring an extremely precise patient positioning system. Schär has fulfilled the demanding requirements to our fullest satisfaction, delivering high quality work and service.”

Mr. Volker Schirrmeister, MSc

– Physicist at Proton Therapy Center Switzerland AG –

„Schär Engineering stands with its high quality products for precision, reliability and long-lastiness. With respect to the quality claim of proton therapy and to justify the relative high investment, these should be the decision criteria for the equipment.”